Tonic arterial chemoreceptor activity contributes to cardiac sympathetic activation in mild ovine heart failure

Experimental Physiology

Volumn 99, Issue 8, 2014, Pages 1031-1041

  Xing, Daniel T ^a,c   May, Clive N ^a   Booth, Lindsea C ^a   Ramchandra, Rohit ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c LATROBE REGIONAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CHEMORECEPTOR; CONTROLLED STUDY; DISEASE SEVERITY; EWE; FEMALE; HEART BEAT; HEART EJECTION FRACTION; HEART FAILURE; HEART NERVE; HEART RATE; HEART VENTRICLE PACING; HYPEROXIA; KIDNEY NERVE; NERVE CONDUCTION; NONHUMAN; OXYGEN THERAPY; PRESSORECEPTOR REFLEX; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; ANIMAL; ARTERY; BLOOD PRESSURE; CHEMORECEPTOR CELL; HEART; PATHOPHYSIOLOGY; PHYSIOLOGY; SHEEP;

ANIMALS; ARTERIES; BAROREFLEX; BLOOD PRESSURE; CHEMORECEPTOR CELLS; HEART; HEART FAILURE; HEART RATE; HYPEROXIA; SHEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 84905261643     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.079491     Document Type: Article

References (43)

1. Abdala AP, McBryde FD, Marina N, Hendy EB, Engelman ZJ, Fudim M, Sobotka PA, Gourine AV & Paton JFR (2012). Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. J Physiol 590, 4269-4277.
2. Al-Hesayen A & Parker JD (2004). Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure. Circulation 109, 2862-2865.
3. Anderson KJ, Harten JM, Booth MG, Berry C, McConnachie A, Rankin AC & Kinsella J (2010). The cardiovascular effects of normobaric hyperoxia in patients with heart rate fixed by permanent pacemaker. Anaesthesia 65, 167-171.
4. Andreas S, Bingeli C, Mohacsi P, Lüscher TF & Noll G (2003). Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 123, 366-371.
5. Briest W, Hölzl A, Rassler B, Deten A, Leicht M, Baba HA & Zimmer HG (2001). Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc Res 52, 265-273.
6. Chen JS, Wang W, Bartholet T & Zucker IH (1991). Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation 83, 260-267.
7. Daly WJ & Bondurant S (1962). Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men-resting, with reactive hyperemia, and after atropine. J Clin Invest 41, 126-132.
8. Del Rio R, Marcus NJ & Schultz HD (2013). Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 62, 2422-2430.
9. Dempsey JA (2012). New perspectives concerning feedback influences on cardiorespiratory control during rhythmic exercise and on exercise performance. J Physiol 590, 4129-4144.
10. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard JM, Lambert G, Esler M & Pathak A (2012). Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 30, 753-760.
11. Dibner-Dunlap ME & Thames MD (1989). Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ Res 65, 1526-1535.
12. DiBona GF & Sawin LL (1994). Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 266, R27-R39.
13. Ding Y, Li YL & Schultz HD (2011). Role of blood flow in carotid body chemoreflex function in heart failure. J Physiol 589, 245-258.
14. Eckberg DL, Drabinsky M & Braunwald E (1971). Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285, 877-883.
15. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W & Lambert G (1988). Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11, 3-20.
16. Floras JS (2001). Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure. Ann N Y Acad Sci 940, 500-513.
17. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB & Pozzi M (1995). Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation 92, 3206-3211.
18. Harten JM, Anderson KJ, Angerson WJ, Booth MG & Kinsella J (2003). The effect of normobaric hyperoxia on cardiac index in healthy awake volunteers. Anaesthesia 58, 885-888.
19. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA & Korner PI (1986). Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73, 615-621.
20. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A & Esler MD (1995). Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26, 1257-1263.
21. Kollai M, Koizumi K & Brooks CM (1978). Nature of differential sympathetic discharges in chemoreceptor reflexes. Proc Natl Acad Sci U S A 75, 5239-5243.
22. Liang C, Rounds NK, Dong E, Stevens SY, Shite J & Qin F (2000). Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial β-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation 102, 96-103.
23. McBryde FD, Abdala AP, Hendy EB, Pijacka W, Marvar P, Moraes DJA, Sobotka PA & Paton JFR (2013). The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun 4, 2395.
24. Marcus NJ, Del Rio R, Schultz EP, Xia XH & Schultz HD (2014). Carotid body denervation improves autonomic and cardiac function and attenuates disordered breathing in congestive heart failure. J Physiol 592, 391-408.
25. Marshall JM (1994). Peripheral chemoreceptors and cardiovascular regulation. Physiol Rev 74, 543-594.
26. Niewiński P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart ECJ, Paton JFR & Ponikowski P (2013). Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol 168, 2506-2509.
27. Paton JFR, Sobotka PA, Fudim M, Engelman ZJ, Hart ECJ, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L & Nightingale A (2013). The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61, 5-13.
28. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, Poole-Wilson PA, Piepoli MF & Coats AJ (2001). Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 104, 544-549.
29. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, Anker SD, Volterrani M, Colombo R, Mazzuero G, Giordano A & Coats AJ (1997). Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 96, 2586-2594.
30. Prabhakar NR (2013). Sensing hypoxia: physiology, genetics and epigenetics. J Physiol 591, 2245-2257.
31. Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM & May CN (2009). Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci U S A 106, 924-928.
32. Ramchandra R, Hood SG, Frithiof R, McKinley MJ & May CN (2013). The role of the paraventricular nucleus of the hypothalamus in the regulation of cardiac and renal sympathetic nerve activity in conscious normal and heart failure sheep. J Physiol 591, 93-107.
33. Ramchandra R, Hood SG, Watson AM, Allen AM & May CN (2012). Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure. Hypertension 59, 634-641.
34. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G & Friberg P (1997). Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95, 169-175.
35. Schultz HD, Li YL & Ding Y (2007). Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50, 6-13.
36. Sobotka PA, Osborn JW & Paton JF (2013). Restoring autonomic balance: future therapeutic targets. EuroIntervention 9 Suppl R, R140-R148.
37. Sun SY, Wang W, Zucker IH & Schultz HD (1999a). Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86, 1264-1272.
38. Sun SY, Wang W, Zucker IH & Schultz HD (1999b). Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86, 1273-1282.
39. van de Borne P, Oren R, Anderson EA, Mark AL & Somers VK (1996). Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation 94, 1325-1328.
40. Vidruk EH, Olson EB Jr, Ling L & Mitchell GS (2001). Responses of single-unit carotid body chemoreceptors in adult rats. J Physiol 531, 165-170.
41. Watson AM, Hood SG, Ramchandra R, McAllen RM & May CN (2007). Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am J Physiol Heart Circ Physiol 293, H798-H804.
42. Watson AM, Mogulkoc R, McAllen RM & May CN (2004). Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. Am J Physiol Regul Integr Comp Physiol 286, R1051-R1056.
43. Xing T & Pilowsky PM (2010). Acute intermittent hypoxia in rat in vivo elicits a robust increase in tonic sympathetic nerve activity that is independent of respiratory drive. J Physiol 588, 3075-3088.